Literature DB >> 25979974

Should Hemoglobin A1C Be Routinely Measured in Patients with CKD?

Nisha Bansal1, Michael G Shlipak2.   

Abstract

Entities:  

Keywords:  CKD; glycated hemoglobin; nondiabetic

Mesh：

Substances：

Year:  2015        PMID： 25979974      PMCID： PMC4455202          DOI： 10.2215/CJN.04200415

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  12 in total

1.  THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?

Authors:  A B HILL
Journal:  Proc R Soc Med       Date:  1965-05

2.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

3.  Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.

Authors:  Claire Trivin; Marie Metzger; Jean-Philippe Haymann; Jean-Jacques Boffa; Martin Flamant; François Vrtovsnik; Pascal Houillier; Benedicte Stengel; Eric Thervet
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

4.  Defining the relationship between average glucose and HbA1c in patients with type 2 diabetes and chronic kidney disease.

Authors:  Clement Lo; Michelle Lui; Sanjeeva Ranasinha; Helena J Teede; Peter G Kerr; Kevan R Polkinghorne; David M Nathan; Hui Zheng; Sophia Zoungas
Journal:  Diabetes Res Clin Pract       Date:  2014-02-03       Impact factor: 5.602

5.  Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.

Authors:  Sabin Shurraw; Brenda Hemmelgarn; Meng Lin; Sumit R Majumdar; Scott Klarenbach; Braden Manns; Aminu Bello; Matthew James; Tanvir Chowdhury Turin; Marcello Tonelli
Journal:  Arch Intern Med       Date:  2011-11-28

6.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

Authors:  Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

7.  Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.

Authors:  Rikke Borg; Judith C Kuenen; Bendix Carstensen; Hui Zheng; David M Nathan; Robert J Heine; Jorn Nerup; Knut Borch-Johnsen; Daniel R Witte
Journal:  Diabetes       Date:  2010-04-27       Impact factor: 9.461

8.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

9.  Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.

Authors:  Vasilios Papademetriou; Laura Lovato; Michael Doumas; Eric Nylen; Amy Mottl; Robert M Cohen; William B Applegate; Zubin Puntakee; Jean Francois Yale; William C Cushman
Journal:  Kidney Int       Date:  2014-09-17       Impact factor: 10.612

10.  Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.

Authors:  Sophia Zoungas; John Chalmers; Bruce Neal; Laurent Billot; Qiang Li; Yoichiro Hirakawa; Hisatomi Arima; Helen Monaghan; Rohina Joshi; Stephen Colagiuri; Mark E Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Liu Lisheng; Giuseppe Mancia; Michel Marre; David R Matthews; Carl E Mogensen; Vlado Perkovic; Neil Poulter; Anthony Rodgers; Bryan Williams; Stephen MacMahon; Anushka Patel; Mark Woodward
Journal:  N Engl J Med       Date:  2014-09-19       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.